Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-07-19
2011-07-19
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S739000
Reexamination Certificate
active
07981933
ABSTRACT:
A method for treating an inflammation or lesion caused by herpesvirus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as herpes simplex. Nasal deliverable forms are effective in treating symptoms due to viruses that cause the common cold. Pharmaceutical compositions for use in the present method are provided.
REFERENCES:
patent: 4513008 (1985-04-01), Revici et al.
patent: 4647458 (1987-03-01), Ueno et al.
patent: 4975217 (1990-12-01), Brown-Skrobot et al.
patent: 5043357 (1991-08-01), Hoffler et al.
patent: 5071650 (1991-12-01), Dove et al.
patent: 5385938 (1995-01-01), Yu et al.
patent: 5405602 (1995-04-01), Simmons et al.
patent: 5492932 (1996-02-01), Kundsin
patent: 5512200 (1996-04-01), Garcia
patent: 5531984 (1996-07-01), Staats
patent: 5534554 (1996-07-01), Katz et al.
patent: 5728404 (1998-03-01), Von Rheinbaben
patent: 5767163 (1998-06-01), Kundsin
patent: 5952392 (1999-09-01), Katz et al.
patent: 6034133 (2000-03-01), Hendley et al.
patent: 6858232 (2005-02-01), Verbiscar
patent: 7045548 (2006-05-01), Konowalchuk et al.
patent: 7268163 (2007-09-01), Konowalchuk et al.
patent: 7279163 (2007-10-01), Holt et al.
patent: 7399790 (2008-07-01), Konowalchuk et al.
patent: 2002/0165279 (2002-11-01), Konowalchuk et al.
patent: 1221640 (1987-05-01), None
patent: 1319605 (1993-06-01), None
patent: 2 187 097 (1987-09-01), None
patent: 63-014702 (1988-01-01), None
patent: 11 087290 (1999-03-01), None
patent: WO 96/11572 (1996-04-01), None
patent: WO 00/62613 (2000-10-01), None
patent: WO 02/069887 (2002-09-01), None
US Office Action dated May 22, 2002 issued in U.S. Appl. No. 10/016,282.
US Final Office Action dated Oct. 22, 2002 issued in U.S. Appl. No. 10/016,282.
US Office Action dated Jun. 13, 2003 issued in U.S. Appl. No. 10/016,282.
US Final Office Action dated Apr. 21, 2004 issued in U.S. Appl. No. 10/016,282.
US Office Action dated Nov. 23, 2004 issued in U.S. Appl. No. 10/016,282.
US Office Action dated Feb. 8, 2005 issued in U.S. Appl. No. 10/016,282.
US Office Action dated Sep. 21, 2005 issued in U.S. Appl. No. 10/016,282.
US Office Action dated Oct. 24, 2001 issued in U.S. Appl. No. 09/795,279.
US Final Office Action dated Feb. 12, 2002 issued in U.S. Appl. No. 09/795,279.
US Office Action dated Sep. 24, 2002 issued in U.S. Appl. No. 09/795,279.
US Final Office Action dated Dec. 31, 2002 issued in U.S. Appl. No. 09/795,279.
US Office Action dated Jul. 15, 2003 issued in U.S. Appl. No. 09/795,279.
US Office Action dated Mar. 24, 2004 issued in U.S. Appl. No. 09/795,279.
US Final Office Action dated Oct. 20, 2004 issued in U.S. Appl. No. 09/795,279.
US Office Action dated Feb. 24, 2006 issued in U.S. Appl. No. 09/795,279.
US Final Office Action dated Jan. 4, 2007 issued in U.S. Appl. No. 09/795,279.
US Notice of Allowance dated Dec. 11, 2007 issued in U.S. Appl. No. 09/795,279.
US Office Action dated Jan. 29, 2002 issued in U.S. Appl. No. 10/016,189.
US Office Action dated Feb. 12, 2002 issued in U.S. Appl. No. 10/016,189.
US Final Office Action dated Oct. 22, 2002 issued in U.S. Appl. No. 10/016,189.
US Office Action dated Jul. 2, 2003 issued in U.S. Appl. No. 10/016,189.
US Final Office Action dated May 14, 2004 issued in U.S. Appl. No. 10/016,189.
US Office Action dated Feb. 7, 2005 issued in U.S. Appl. No. 10/016,189.
US Notice of Allowance dated Nov. 16, 2005 issued in U.S. Appl. No. 10/016,189.
US Office Action dated Feb. 12, 2002 issued in U.S. Appl. No. 10/021,533.
US Final Office Action dated Oct. 28, 2002 issued in U.S. Appl. No. 10/021,533.
US Office Action dated Jul. 2, 2003 issued in U.S. Appl. No. 10/021,533.
US Final Office Action dated Apr. 20, 2004 issued in U.S. Appl. No. 10/021,533.
US Final Office Action dated Nov. 23, 2004 issued in U.S. Appl. No. 10/021,533.
US Office Action dated Feb. 7, 2005 issued in U.S. Appl. No. 10/021,533.
US Notice of Allowance dated Apr. 17, 2007 issued in U.S. Appl. No. 10/021,533.
PCT International Search Report dated Sep. 18, 2002 issued in PCT/US/2002/04273 (WO 2002/069887).
PCT Written Opinion dated Oct. 24, 2003 issued in PCT/US/2002/04273 (WO 2002/069887).
PCT Preliminary Examination Report dated Dec. 19, 2003 issued in PCT/US/2002/04273 (WO 2002/069887).
Australian Examiner's First Report dated May 11, 2006 issued in Patent App. No. 2002251933.
Australian Examiner's First Report dated Nov. 14, 2008 issued in Patent App. No. 2008201666.
Chinese Office Action dated Jun. 10, 2005 issued in Patent App. No. 02809063.2.
Chinese Certificate of Invention Patent No. 274143 issued on Jul. 19, 2006.
Eurasian Certificate of Grant No. 005917 dated Jun. 30, 2005.
European Search Report dated Feb. 16, 2004 issued in EP Application No. 02 720 972.5 (Dated Feb. 15, 2004, 7,045,548).
European Examination dated Apr. 28, 2006 issued in EP Application No. 02 720 972.5.
European Examination dated Dec. 17, 2007 issued in EP Application No. 02 720 972.5.
Israeli Description of Office of Conununication dated Jan. 23, 2007 issued in Patent Application No. 157596.
Israeli Description of Office Action dated Jun. 17, 2007 issued in Patent Application No. 157596.
Israeli Office Action dated May 4, 2008 issued in Patent Application No. 157596.
Japanese Office Action dated Sep. 30, 2008 issued in Patent Application No. 2002-569066.
Korean Description of Office Action dated Jan. 4, 2008 issued in Patent Application No. 10-2003-7011326.
Korean Office Action dated Jul. 4, 2008 issued in Patent Application No. 10-2003-7011326.
Mexican Description of Office Action dated May 7, 2007 issued in Patent Application No. PA/a/2003/007748.
Mexican Description of Office Action dated May 13, 2008 issued in Patent Application No. PA/a/2003/007748.
Mexican Description of Office Action dated Dec. 24, 2008 issued in Patent Application No. PA/a/2003/007748.
New Zealand Examination Report dated Jan. 26, 2005 issued in Patent Application No. 527931.
New Zealand Examination Report dated Jan. 6, 2006 issued in Patent Application No. 527931.
Philippine Office Action dated Jun. 23, 2006 issued in Patent Application No. 1-2003-500789.
Philippine Office Action dated Nov. 12, 2008 issued in Patent Application No. 1-2003-500789.
Singapore Certificate of Grant dated Mar. 31, 2006 for Patent No. 98871.
Bhatia and Soman, (1998) “Evaluation of virucidal activity of a few physicochemical agents against goat-pox virus”Indian Jnl of Animal Sciences, 68(6): 518-520.
Dobkin, Milton et al., (1991) “Virucidal Efficacy of Saturated Intermediate Length Straight-chain Alcohols in Biologically Active Protein Solutions”,Biologicals19:177-185.
Konowalchuk and Speirs, (1976) “Virus Inactivation by Grapes and Wines”,Applied and Env Microbiology, 32:757-763.
Lueck, (1980) “Antimicrobial Food Additives”, published bySpringer-Verlag, pp. 136-139, 159-165, and 167-173.
Merck Index, (1989) 11thEd., Glycolic acid monograph 4394, p. 4399.
Poli et al., (1978) “Virucidal Activity of Organic Acids”,Food Chemistry, 4(3):250-258.
Remington's Pharmaceutical Sciences, (1990) 18thEd., pp. 218-219 and 1314-1315.
Snipes, et al., (1977) “Inactivation of Lipid-Containing Viruses by Long-Chain Alcohols”,Antimicrobial Agents and Chemotherapy, 11:98-104.
“Disinfectant Drugs”, (Apr. 1999)Therapeutic Products Programme Guidelinespublished by Health Canada, pp. 42-45.
Wenninger et al., (1997)International Cosmetic Ingredient Dictionary and Handbook, 7thEd., vol. 1, pp. 163-168.
US Office Action (Notice of Non-Compliant Amendment) dated Jul. 21, 2009 issued in U.S. Appl. No. 10/016,282.
US Office Action (Examiner Interview Summary) dated Sep. 21, 2009 issued in U.S. Appl. No. 10/016,282.
US Final Office Action dated Nov. 27, 2009 issued in U.S. Appl. No. 10/016,282.
Canadian Office Action dated Jan. 14, 2009 is
Konowalchuk Jack
Konowalchuk Thomas W.
Hui San-ming
Life Force Technologies, LLC
Weaver Austin Villeneuve & Sampson LLP
LandOfFree
Method for treating an inflammation or lesion caused by a virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating an inflammation or lesion caused by a virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating an inflammation or lesion caused by a virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2720781